KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Yu, Bo, Luo, Fei, Sun, Bowen, Liu, Wenxue, Shi, Qiqi, Cheng, Shi‐Yuan, Chen, Ceshi, Chen, Guoqiang, Li, Yanxin, Feng, Haizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787397/
https://www.ncbi.nlm.nih.gov/pubmed/35075800
http://dx.doi.org/10.1002/advs.202105793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787397/
https://www.ncbi.nlm.nih.gov/pubmed/35075800
http://dx.doi.org/10.1002/advs.202105793

Ejemplares similares